Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Glumetza Patent Settlement Without An Authorized Generic Plus Price Hike Spawns Litigation
Dec 03 2019
•
By
Brenda Sandburg
Walgreen and other direct purchasers and end payers allege Glumetza patent litigation settlement led to Valeant price hike
More from Legal & IP
More from Pink Sheet